✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Cytokinetics Inc

Common Name
Cytokinetics
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
498
Ticker
CYTK
Exchange
NASDAQ/NGS
Description
Cytokinetics, Incorporated is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors. These...

Cytokinetics's Waste Data Preview

In 2023, Cytokinetics conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards.The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.

Metric (tonnes)20232022
Total Waste Generated
105.96a
N/A
Total Waste Recovered
64.12a
N/A
Total Hazardous Waste Generated
18.36a
13.22a
Non-Hazardous Waste Disposed
27.05a
N/A
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Cytokinetics’s Waste Management Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Cytokinetics's Corporate Responsibility Report (CRR) 2023

Insights into Cytokinetics's Waste Treatment Practices

In 2023, Cytokinetics generated a total of 106metric tonnes of waste.a

Of this amount, 60.51% of Cytokinetics's total waste generated was recovered through methods such as recycling, reuse, or composting, while 39.49% was disposed of through landfilling, incineration, or combustion.a

Cytokinetics's Waste Recovery Rate

61%

How much of Cytokinetics's waste is recycled or recovered?

In 2023, Cytokinetics reported a total waste generation of 106 metric tonnes, of which 60.51% was recovered through recycling, reuse, or composting.This moderate level of recovery indicates that Cytokinetics is taking steps toward improving its waste diversion practices, though there is still room to enhance recycling and recovery efforts.a

Insights into Cytokinetics’s Generation of Hazardous and Non-Hazardous Waste

In 2023, Cytokinetics generated a total of 106 metric tonnes of waste.a

Of this amount, 17.33% of Cytokinetics's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment.82.67% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.a

How does Cytokinetics treat its hazardous waste?

In 2023, Cytokinetics reported that 18 metric tonnes of its total waste output were classified as hazardous. This represents 17.33% of its overall waste generation.a

The company treated this hazardous waste using a combination of methods.Approximately 19.44% was managed through recovery methods, indicating a moderate integration of circular practices into its hazardous waste management. However, a significant share was still directed toward disposal, highlighting room for improvement in reducing the long-term impact of hazardous materials.a

Breakdown of Cytokinetics's Hazardous and Non-Hazardous Waste by Treatment Method

Hazardous WasteDisposed(14.0%)Non-Hazardous WasteDisposed(25.5%)Non-Hazardous WasteRecovered(57.1%)
Want Full Access to Cytokinetics's Waste Management Dataset?
Start 30-Day Free Trial